Depression and Anxiety Trial, Recruiting (NCT05388461)

Depression and Anxiety Trial, Recruiting NCT05388461 Sponsor: Haukeland University Hospital Condition: Depression and Anxiety

Printed from Voxsanity (voxsanity.com.au) — NCT05388461 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Depression And Anxiety

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You received electroconvulsive therapy (ECT) — a treatment that uses electrical stimulation to the brain — for major depression at either Haukeland University Hospital or Stavanger University Hospital after 2013.
You have given written permission to have your information included in the Regional Register for neurostimulation (a database that tracks brain stimulation treatments).

Who may not be able to join:

Your ECT treatment was given for a reason other than major depression.
You have not given consent to have your information included in the register.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 30 June 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05388461

Sponsor: Haukeland University Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Depression and Anxiety

More information: https://clinicaltrials.gov/study/NCT05388461

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You received electroconvulsive therapy (ECT) — a treatment that uses electrical stimulation to the brain — for major depression at either Haukeland University Hospital or Stavanger University Hospital after 2013.
You have given written permission to have your information included in the Regional Register for neurostimulation (a database that tracks brain stimulation treatments).

Who may not be able to join:

Your ECT treatment was given for a reason other than major depression.
You have not given consent to have your information included in the register.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 30 June 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Haukeland University Hospital

Registry

ClinicalTrials.gov

Start date

13 March 2013

Est. completion

1 December 2028

Where this trial is recruiting

🇳🇴 Norway

Primary endpoints

Change of Montgomery and Åsberg Depression Rating Scale (MADRS) score from pretreatment at posttreatment; MADRS range 0 - 60, with higher scores indicating more severe depression); Change of Mini Mental State Examination (MMSE-NR) score from pretreatment at posttreatment; MMS-E range 0-30 with lower scores indicating more severe cognitive impairment; Change of Beck depression inventory (BDI) score from pretreatment at posttreatment; BDI range 0-63, with higher scores indicating more severe depression; Change of Everyday Memory Questionnaire (EMQ) score from pretreatment at posttreatment with h...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov